Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD”

1,686 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,686 results

Not applicableStudy completedNCT05792423
What this trial is testing

Conditionally Increased Output (CIO) Enhanced Ultrasound System

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFatty Liver
Massachusetts General Hospital 24
Early research (Phase 1)Study completedNCT04812262
What this trial is testing

DD01 in Overweight/Obese Subjects With T2DM and NAFLD

Who this might be right for
Overweight and ObesityType2 DiabetesNAFLD
Neuraly, Inc. 255
Not applicableUnknownNCT06130202
What this trial is testing

Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Assiut University 165
Not applicableStudy completedNCT01371396
What this trial is testing

Effect of Dietary Macronutrient Composition

Who this might be right for
Metabolic SyndromeNon-alcoholic Fatty Liver DiseaseObesity
University of Texas Southwestern Medical Center 24
Post-approval studies (Phase 4)Study completedNCT04642261
What this trial is testing

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease
The University of Hong Kong 98
Not applicableStudy completedNCT02647294
What this trial is testing

Polyunsaturated Fatty Acids in Patients With NAFLD.

Who this might be right for
NAFLD
General University Hospital, Prague 60
Testing effectiveness (Phase 2)Ended earlyNCT03281083
What this trial is testing

Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Duke-NUS Graduate Medical School 29
Testing effectiveness (Phase 2)Ended earlyNCT04065841
What this trial is testing

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 234
Not applicableStudy completedNCT06398522
What this trial is testing

Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome

Who this might be right for
NAFLDMetabolic Syndrome
University of Bologna 50
Not applicableStudy completedNCT03942822
What this trial is testing

Chia Supplementation and Non Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDietary Modification
Instituto Nacional de Cardiologia Ignacio Chavez 40
Large-scale testing (Phase 3)Study completedNCT02535195
What this trial is testing

Effect of Ginger Supplement on Non-alcoholic Fatty Liver

Who this might be right for
Non-alcoholic Fatty Liver Disease
Dr Azita Hekmatdoost 60
Testing effectiveness (Phase 2)Study completedNCT04134091
What this trial is testing

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Lipocine Inc. 56
Testing effectiveness (Phase 2)Ended earlyNCT04048876
What this trial is testing

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Cirrhosis
Celgene 56
Not applicableUnknownNCT03254563
What this trial is testing

Copeptin and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
University of Colorado, Denver 60
Not applicableNot Yet RecruitingNCT06520800
What this trial is testing

Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise

Who this might be right for
Adolescent ObesityHypertension,EssentialNon-Alcoholic Fatty Liver Disease+3 more
University of Lisbon 24
Not applicableUnknownNCT02298439
What this trial is testing

Fatty Liver Patient Registry

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Health Network, Toronto 100
Not applicableStudy completedNCT04527965
What this trial is testing

Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 Diabetes

Who this might be right for
NAFLDDiabetes Mellitus, Type 2PreDiabetes
Uppsala University 150
Not applicableNot Yet RecruitingNCT06691529
What this trial is testing

Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease

Who this might be right for
Fatty Liver DiseaseChronic Glomerular Disease
Assiut University 500
Early research (Phase 1)Study completedNCT02918929
What this trial is testing

EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

Who this might be right for
Presumptive NAFLD
Enanta Pharmaceuticals, Inc 146
Not applicableStudy completedNCT04509245
What this trial is testing

The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver, Nonalcoholic
German Diabetes Center 24
Next Page